These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9795300)
1. [Treatment of pneumonia caused by Legionella with azithromycin]. Sánchez F; Mensa J; Martínez JA; Badia R; Albarracín M; Losa JE; Ruiz M; Marcos MA; Torres A; Soriano E Rev Esp Quimioter; 1998 Jun; 11(2):147-51. PubMed ID: 9795300 [TBL] [Abstract][Full Text] [Related]
2. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670 [TBL] [Abstract][Full Text] [Related]
3. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Griffin AT; Peyrani P; Wiemken T; Arnold F Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309 [TBL] [Abstract][Full Text] [Related]
4. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases]. Benito JR; Montejo JM; Cancelo L; Zalacaín R; López L; Fernández Gil de Pareja J; Alonso E; Oñate J Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):394-400. PubMed ID: 14525703 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Mykietiuk A; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F Clin Infect Dis; 2005 Mar; 40(6):794-9. PubMed ID: 15736010 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. Kuzman I; Soldo I; Schönwald S; Culig J Scand J Infect Dis; 1995; 27(5):503-5. PubMed ID: 8588143 [TBL] [Abstract][Full Text] [Related]
7. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825 [TBL] [Abstract][Full Text] [Related]
8. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069 [TBL] [Abstract][Full Text] [Related]
10. [Three patients with pneumonia due to Legionella associated with a sauna, a cooling tower and a caravan in The Netherlands]. Bencini MA; IJzerman EP; Bruin JP; den Boer JW Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1973-7. PubMed ID: 16171106 [TBL] [Abstract][Full Text] [Related]
11. A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful. Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T; Fujii H; Hashimoto T; Nakajima H; Amemura-Maekawa J Jpn J Infect Dis; 2017 Nov; 70(6):660-662. PubMed ID: 28890505 [TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila. Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113 [No Abstract] [Full Text] [Related]
13. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Sánchez F; Mensa J; Martínez JA; García E; Marco F; González J; Marcos MA; Soriano A; Torres A Clin Infect Dis; 2003 May; 36(10):1239-45. PubMed ID: 12746768 [TBL] [Abstract][Full Text] [Related]
14. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. Tan JS; File TM; DiPersio JR; DiPersio LP; Hamor R; Saravolatz LD; Stout JE Clin Infect Dis; 2001 Jun; 32(11):1562-6. PubMed ID: 11340527 [TBL] [Abstract][Full Text] [Related]
15. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Bartlett JG Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295 [TBL] [Abstract][Full Text] [Related]
16. [Treatment for Legionnaires' disease. Macrolides or quinolones?]. Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936 [TBL] [Abstract][Full Text] [Related]
17. Legionnaires disease with bacteremic coinfection. Tan MJ; Tan JS; File TM Clin Infect Dis; 2002 Sep; 35(5):533-9. PubMed ID: 12173126 [TBL] [Abstract][Full Text] [Related]
18. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6. Chen CY; Chen KY; Hsueh PR; Yang PC J Formos Med Assoc; 2006 Mar; 105(3):256-62. PubMed ID: 16520845 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Dunbar LM; Khashab MM; Kahn JB; Zadeikis N; Xiang JX; Tennenberg AM Curr Med Res Opin; 2004 Apr; 20(4):555-63. PubMed ID: 15119993 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation. Engel MF; van Manen L; Hoepelman AI; Thijsen S; Oosterheert JJ J Clin Pathol; 2013 Sep; 66(9):797-802. PubMed ID: 23775436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]